Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets


ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Review Article

The use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases

Author(s): Gholamreza Azizi, Hassan Abolhassani, Mohammad Hosein Asgardoon, Javad Rahnavard, Majid Zaki dizaji, Reza Yazdani, Javad Mohammadi and Asghar Aghamohammadi

Volume 16, Issue 2, 2016

Page: [80 - 88] Pages: 9

DOI: 10.2174/1871530316666160724214418

Price: $65


Immunoglobulin therapy represents a lifesaving intervention for many patients with primary immunodeficiency (PID). Antibody defects represent approximately half of the well-known PIDs requiring immunoglobulin replacement therapy. Following immunoglobulin therapy in PID patients, protection against serious upper and lower respiratory tract infections and pulmonary function improves which leads to an increase in the quality of life of these patients. Successful treatment of PID patients depends on the type of immunodeficiency, regular monitoring of the patient, comorbidities of the patient, and the availability of the products.

Keywords: Immunoglobulin, infection, primary antibody deficiency, primary immunodeficiency diseases.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy